Skip Ribbon Commands
Skip to main content
Sign In

Pages :bUse SHIFT+ENTER to open the menu (new window).Open MenuOpen Menu
This system library was created by the Publishing feature to store pages that are created in this site.

Synonyms, Keywords
Test Components
26106OMSC1B2B CBC with Auto Differential
HGMPS and AD: (White blood cell count, red blood cell count, hemoglobin, hematocrit, mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, red cell distribution width, platelet, mean platelet volume, percent/absolute neutrophils, lymphocytes, monocytes, eosinophils, and basophils.​)
 
Certain results and instrument flags will reflex peripheral smear review.  Click on the link below to view slide review criteria.
 
26105OMRUAB2B Urine (Dipstick & Micro)
​STIX and Micro: (Color, Turbidity, Specific Gravity, pH, Protein, Glucose, Ketone, Bile, Blood, Urobilinogen, Esterase, and Nitrite, Casts, Renal Epithelial cells, WBC, RBC, Squamous cells, and Bacteria).
25525BABGSOBabesia microti IgG Antibodies, Serum (BABG)

​Babesiosis Serology

25230BABNATBabesia microti, Nucleic Acid Test
Babesia PCR, Babesiosis PCR
22343BABEBabesia Smear
​Babesia microti, Giemsa Stain​
26138BRBPSSOBacteria PCR & Sequence (BRBPS)
16S rRNA gene sequencing
Bacterial sequencing
Broad range
Broad-range
16S
Broad
Mycobacteria
Mycobacterial
Ribosomal RNA
rRNA
Sequencing
Next Generation Sequencing
NGS

If polymerase chain reaction (PCR) testing is negative, no sequencing is performed, and the test is resulted as negative.

If PCR testing is positive, sequencing is performed. Strong positive results are first submitted to Sanger sequencing, which can yield results in as few as 4 days. Weak positive results, or Sanger sequencing results that are mixed, are submitted to next-generation sequencing (ie, targeted metagenomics testing).

26122CFRCSOBacterial Culture, Cystic Fibrosis with Antimicrobial Susceptibilities (CFRCS)
22345BARBarbiturates, Urine
Amobarbital, Amytal, Phenobarbital, Luminal, Nembutal, Pentobarbital. Secobarbital, Seconal, Solfoton , Phenobarbital, Butalbital, Fiorinal​
25091CO-BARBarbiturates, Urine, Confirm Only by GCMS
Amobarbital, Amytal, Phenobarbital, Luminal, Nembutal, Pentobarbital. Secobarbital, Seconal, Solfoton, Phenobarbital, Butalbital, Fiorinal​
25412BARTPANBartonella Ab Panel, IgG & IgM (BART)
​Bartonella henselae Abs, IgG/IgM; Bartonella quintana, IgG/IgM; Cat Scratch Disease, Bartonellosis, BART
26208BCLLSOB-Cell IGH Hypermutation Analysis (BCLL)

​BCLL
IGVH
IGHV
Next Gen Sequencing Test
Somatic mutation (or Hypermutation)
CLL prognosis

25628BLYMFSOB-Cell Lymphoma Tissue, FISH (BLYM)
BLYM
BCL2 (18q21) rearrangement
BCL6 (3q27) rearrangement
Burkitt lymphoma
Burkitt-like lymphoma
CCND2
Diffuse Large Cell Lymphoma/"Double Hit"
Follicular lymphoma
Large BCL with IRF4 rearranged
MALT (18q21) rearrangement
MALT lymphoma
Mantle Cell Lymphoma (MCL)
MYC (8q24.1) rearrangement
MYC/Kappa
MYC/Lambda
Splenic Marginal Zone Lymphoma
t(11;14) (q13;q32) - CCND1/IGH
t(11;18) (q21;q21) - BIRC3/MALT1
t(14;18) (q32;q21) - IGH/MALT1
t(14;18)(q32;q21) - IGH/BCL2
t(2;8)(p12;q24) - IGK/MYC
t(8;14) (q24.1;q32) - MYC/IGH
t(8;22) (q24.1;q11.2) - MYC/IGL
IRF4
DUSP22
TNFRSF14
1p36

This test does not include a pathology consultation. If a pathology consultation is desired, PATHC / Pathology Consultation should be ordered and the appropriate FISH test will be ordered and performed at an additional charge. Mayo Hematopathology Consultants are involved in both the preanalytic (tissue adequacy and probe selection, when applicable) and postanalytic (interpretation of FISH results in context of specific case, when applicable) phases.

Depending on the lymphoma subtype suspected, the most appropriate probes to order are listed in the table: Common Chromosome Abnormalities in B-cell Lymphomas in Clinical Information.

If the patient is being tracked for known abnormalities, indicate which probes should be used.

A charge and CPT code is applied for each probe set hybridized, analyzed, and reported.

Initial probe sets are run and completed within 4 days. If, based on testing algorithms, results of the initial probe sets require reflex testing, complete results will be available within 10 days. 

25629BLPFSOB-Cell Lymphoma, FISH Bld/BM  (BLPF)
​17p- (17p deletion) or TP53
BCL2 (18q21) rearrangement
BCL6 (3q27) rearrangement
Burkitt Lymphoma
Burkitt-like Lymphoma
Diffuse Large Cell Lymphoma/"Double Hit"
Follicular Lymphoma
MALT (18q21) rearrangement
MALT Lymphoma
Mantle Cell Lymphoma (MCL)
MYC (8q24.1) rearrangement
MYC/Kappa
MYC/Lambda
Splenic Marginal Zone Lymphoma
t(11;14)(q13;q32) - CCND1/IGH
t(2;8)(p12;q24) - IGK/MYC
t(8;14)(q24.1;q32) - MYC/IGH
t(8;22)(q24.1;q11.2) - MYC/IGL
Extra-nodal Marginal Zone Lymphoma (ENMZL)
Triple hit lymphoma

This test includes a charge for application of the first probe set (2 FISH probes) and professional interpretation of results. Additional charges will be incurred for all reflex probes performed. Analysis charges will be incurred based on the number of cells analyzed per probe set. If no cells are available for analysis, no analysis charges will be incurred.

When this test and flow cytometry testing for leukemia/lymphoma are ordered concurrently, the flow cytometry result will be utilized to determine if sufficient clonal B-cells are available for FISH testing. If the result does not identify a sufficient clonal B-cell population, this FISH test order will be canceled and no charges will be incurred.

If FISH testing proceeds, probes will be performed based on the lymphoma subtype suspected/identified utilizing the table "Common Chromosome Abnormalities in B-cell Lymphomas" located in Clinical Information.

If the patient is being tracked for known abnormalities, indicate which probes should be used.

The following probe sets are available within this B-cell lymphoma FISH profile:

-8q24.1 rearrangement, MYC

-t(8;14), MYC/IGH

-18q21 rearrangement, BCL2

-3q27 rearrangement, BCL6

-t(11;14), CCND1/IGH

-17p deletion, TP53/D17Z1

-7q deletion, D7Z1/7q32

-18q21 rearrangement, MALT1

Marginal zone lymphoma (MZL) can be evaluated via probes for specific subtypes, as follows: mucosa-associated lymphoid tissue (MALT) lymphoma or extra-nodal marginal zone lymphoma (ENMZL) using the MALT1 rearrangement probe and splenic marginal zone lymphoma using probes for 7q deletion and 17p deletion. If no MZL subtype is provided, we will evaluate using probes for MALT1, 7q deletion and 17p deletion. 

25401BCRAMSOBCR/ABL, p210, RT-PCR(BCRAB)
Acute lymphoblastic leukemia (ALL)
Acute myeloid leukemia (AML)
B lymphoblastic leukemia (B-ALL)
T lymphoblastic leukemia (T-ALL)
BCR-ABL1
BCR ABL
BCR/ABL
Chronic myelogenous leukemia (CML)
Philadelphia chromosome, Ph bone marrow/blood
t(9;22)
Tyrosine kinase inhibitor (TKI) therapy monitoring, PCR
25411BCRADSOBCR/ABL-1 RNA-Qual Diagnostic (BADX)
Philadelphia chromosome Ph bone marrow/blood
Acute lymphoblastic leukemia (ALL)
Acute myeloid leukemia (AML)
BCR-ABL1
BCR ABL
BCR/ABL
B lymphoblastic leukemia (B-ALL)
Chronic myelogenous leukemia (CML)
Chronic myeloid leukemia
T lymphoblastic leukemia (T-ALL)
t(9;22)

​This test is only qualitative and should not be used for routine monitoring (ie, quantitative mRNA level).

Monitoring of most patients with chronic myeloid leukemia (CML) should be performed using BCRAB / BCR/ABL, p210, mRNA Detection, Reverse Transcription-PCR (RT-PCR), Quantitative, Monitoring Chronic Myelogenous Leukemia (CML), Varies.

Monitoring of patients known to carry a p190 fusion should be performed using BA190 / BCR/ABL, p190, mRNA Detection, Reverse Transcription-PCR (RT-PCR), Quantitative, Monitoring Assay, Varies.

25546BC190SOBCR/ABL1, p190, mRNA Detection, Reverse Transcription-PCR (RT-PCR), Quantitative, Monitoring Assay, Varies (BA190)
Philadelphia chromosome, Ph bone marrow/blood
Acute lymphoblastic leukemia (ALL)
Acute myeloid leukemia (AML)
B lymphoblastic leukemia (B-ALL)
BCR ABL
BCR/ABL
BCR-ABL1
T lymphoblastic leukemia (T-ALL)
t(9;22)
22346BENZBenzodiazepines, Urine
Clonazepam, Temazepam, Diazepam, Chlordiazepoxide, Alprazolam, Flunitrazepam, Flurazepam, Nordiazepam, Chlorazepate, Lorazepam, Xanax, Librium, Valium, Ativan, Serax, Restoril​, Date Rape Drug, 7-Aminoflunitrazepam, Roofies, Rohypnol
​The immunoassay screening test for the Benzodiazepines drug class does not detect Lorazepam or Clonazepam well.  If either of these drugs are suspected, please order the test “Benzodiazepines, Urine, Confirm Only by LC/MSMS” in addition to this test to insure detection if present.
25092CO-BENZBenzodiazepines, Urine, Confirm Only by LCMS/MS
Clonazepam, Temazepam, Diazepam, Chlordiazepoxide, Alprazolam, Flunitrazepam, Flurazepam, Nordiazepam, Chlorazepate, Lorazepam, Xanax, Librium, Valium, Ativan, Serax, Restoril​, Date Rape Drug, 7-Aminoflunitrazepam, Roofies, Rohypnol
23169B2IGABeta 2 Glycoprotein 1 IgA
B2IgA, Beta 2 Glycoprotein
23168B2IGGBeta 2 Glycoprotein 1 IgG
B2IgG, Beta 2 Glycoprotein​
23167B2IGMBeta 2 Glycoprotein 1 IgM
B2IgM, Beta 2 Glycoprotein​
26319B2IGABeta 2 Glycoprotein 1, IgA
26320B2IGGBeta 2 Glycoprotein 1, IgG
26321B2IGMBeta 2 Glycoprotein 1, IgM
22347B2MBeta-2 Microglobulin
B2M​, B2MICRO
22348B2MRUSOBeta-2 Microglobulin, Urine (B2MU)
B2M, (Beta-2 Microglobulin) Urine; Beta 2 Microglobulin Test, Beta-2 Microglobulin, Urine
24795B2TRNSOBeta-2 Transferrin: Detection of Spinal Fluid in Other Body Fluid (BETA2)
B2 Transferrin; Cerebrospinal Fluid Leakage; CSF Specific Transferrin; CSF-Specific Transferrin; Otorrhea, Spinal Fluid;
Rhinorrhea, Spinal Fluid; Tau Protein; Transferrin B2; Transferrin, Spinal Fluid
24970BCTXSOBeta-Crosslaps (Beta-CTx), Serum (CTX)
B-CTx, Beta CrossLaps, Beta-CTx, C-Telopeptide, C-terminal collagen crosslinks, Carboxy terminal collagen crosslinks, CTx
22242BOHBeta-Hydroxybutyrate
Hydroxybutyrate, Ketones, 3-hydroxybutyrate
22244CO2Bicarbonate
HCO3, CO2, Total CO2​
24984BACIDSOBile Acids, Total Serum (BILEA)
Bile Salts Total
22246BILE-UBile, Urine
Bilirubin, Urine​
22248DBILBilirubin, Direct Only
DBIL, Conjugated Bilirubin​, Fractionated Bilirubin
22249NBILIBilirubin, Neonatal
NBili, Neonatal Bilirubin​
Total Bilirubin, Direct Bilirubin
Indirect Bilirubin will be calculated​
22250TBILBilirubin, Total Only
TBil, Total Bilirubin​
22251TBIL-OBilirubin, Total, Other Body Fluids
Body Fluid Total Bilirubin​
23318BIOTESOBioavailable Testosterone, Total and Free (TTFB)
​Androgens, Bioavailable Testosterone, NonSex Hormone Binding Globulin (SHBG), Testosterone Group, Testosterone, Total Only, Serum

​Testosterone, Total

Testosterone, Free

Testosterone, Bioavailable

22252BIOTSSOBiotinidase, Serum (BIOTS)
Biotin-amide amidohydrolase, Biotinidase deficiency, BTD
24849QBKSOBK Virus PCR, Qnt, Plasma (QBK)
BKV DNA
BKV Quantitative DNA
Polyomavirus
QBK
BK (Polyoma) Virus
23421BKQNTSOBK Virus PCR, Qnt, Urine (QBKU)
BK PCR Quant
BK Virus
BKV DNA
BKV Quantitative DNA
Polymavirus
QBK
BK (Polyoma) Virus
26053LCBKPSOBK Virus PCR, Qual, Plasma (LCBKP)
BK (Polyoma) Virus, BKV DNA, BKV Qualitative DNA, Polyomavirus
23317BKVIRSOBK Virus PCR, Qual, Urine (LCBK)
BK (polyoma) virus, BKV, BKV DNA, BKV Qualitative DNA, Polyomavirus
22377BLASTOBlastomyces Antibody
Blastomyces, antibody, serology
26173BLCAGSOBlastomyces Quantitative Antigen, CSF and BAL (316)
25016BLSAGSOBlastomyces Quantitative Antigen, Serum (316)
​Blastomyces Dermatitidis QNT AG
25581BLUAGSOBlastomyces Quantitative Antigen, Urine (316)

​Blastomyces Dermatitidis QNT AG

26100CHR2NICBLIPO, Glucose and Nicotine
​Concert Health, CHR
​Includes GLU, BLIPO (Total Cholesterol, HDL Cholesterol, Triglyceride, calculated LDL cholesterol and NONHDL Cholesterol), and NICTS (Nicotine and Metabolites).
22256ABGHBlood Gases and Hemoglobin, Arterial
Art. Blood Gas w/Hgb ​
Panel includes Blood Gas (pH, partial pressure of carbon dioxide pCO2, partial pressure of oxygen pO2, bicarbonate HCO3, base excess BE, O2 Saturation) and Hemoglobin results.​
22257VBGHBlood Gases and Hemoglobin, Venous
Venous Bld Gases w/Hgb​
Panel includes Blood Gas (pH, partial pressure of carbon dioxide pCO2, partial pressure of oxygen pO2, base excess BE, O2 Saturation, calculated HCO3-Marshfield Only), and Hemoglobin​
22258ABGLBlood Gases and NA/K/IC, Arterial
Blood Gas, Art. w/ Sodium, Potassium, Ionized Calcium​
Panel includes Blood Gas (pH, partial pressure of carbon dioxide pCO2, partial pressure of oxygen pO2, bicarbonate HCO3, base excess BE, O2 Saturation) and Sodium, Potassium, and Ionized Calcium​
22259CBGLBlood Gases and Na/K/Ic, Capillary
Blood Gas, Cap. w/ Sodium, Potassium, Ionized Calcium​
Panel includes Blood Gas (pH, partial pressure of carbon dioxide pCO2, partial pressure of oxygen pO2, bicarbonate HCO3, base excess BE, O2 Saturation), Sodium, Potassium, and Ionized calcium​
22260VBGLBlood Gases and Na/K/Ic, Venous
Ven.Bld.Gases & Na/K/Ion.Ca ​
Panel includes Blood Gas (pH, partial pressure of carbon dioxide pCO2, partial pressure of oxygen pO2, base excess BE, O2 Saturation, calculated HCO3-Marshfield Only), Sodium, Potassium, and Ionized calcium​
22261ABGBlood Gases, Arterial
Art.Blood Gas, ABG, PCO2, PO2​
Panel includes Blood Gas (pH, partial pressure of carbon dioxide pCO2, partial pressure of oxygen pO2, bicarbonate HCO3, base excess BE, O2 Saturation)​
22262CBGBlood Gases, Capillary
CBG, Capillary Blood Gases​
Panel includes Blood Gas (pH, partial pressure of carbon dioxide pCO2, partial pressure of oxygen pO2, bicarbonate HCO3, base excess BE, O2 Saturation)​
22265VBGNAKBlood Gases, Na/K, Venous
Venous Bld, Gases & Na/K​
Panel includes Blood Gas (pH, partial pressure of carbon dioxide pCO2, partial pressure of oxygen pO2, base excess BE, O2 Saturation, calculated HCO3-Marshfield Only), Sodium, and Potassium​
22264VBGLHBlood Gases, Na/K/Ic and Hemoglobin, Venous
Ven.Bld.Gases & Na/K/Ion.Ca w/Hgb​
Panel includes Blood Gas (pH, partial pressure of carbon dioxide pCO2, partial pressure of oxygen pO2, base excess BE, O2 Saturation calculated HCO3-Marshfield Only), Sodium, Potassium, Ionized calcium, and Hemoglobin​
22263ABGLHBlood Gases, NA/K/IC, AND Hemoglobin, Arterial
Blood gas with Hgb, Sodium, Potassium and Ionized Calcium​
Panel includes Blood Gas (pH, partial pressure of carbon dioxide pCO2, partial pressure of oxygen pO2, bicarbonate HCO3, base excess BE, O2 Saturation) and Sodium, Potassium, Ionized Calcium, and Hemoglobin results.​
22266UABGBlood Gases, Umbilical Cord Arterial
Cord Gas, Arterial

Panel includes Blood Gas (pH, partial pressure of carbon dioxide pCO2, partial pressure of oxygen pO2,  base excess BE)​

22267UVBGBlood Gases, Umbilical Cord Venous
Cord Gas, Venous​

Panel includes Blood Gas (pH, partial pressure of carbon dioxide pCO2, partial pressure of oxygen pO2,  base excess BE)​

22268VBGBlood Gases, Venous
Venous Blood Gases, VBG​
Panel includes Blood Gas (pH, partial pressure of carbon dioxide pCO2, partial pressure of oxygen pO2, base excess BE, O2 Saturation, calculated HCO3-Marshfield Only) ​
22269ABO/RHBlood Typing, ABO and RH
​ABO Grouping, ABO/RH, Type and Rh, ABO/RH Typing, BB - Blood Type, ABO & Rh
25028BALLFSOB-Lymphoblastic Leukemia/Lymphoma, FISH (BALLF)
+4,+10,+17
17p- (17p deletion) or TP53
9p- (9p deletion) or CDKN2A or p16
Hyperdiploidy
IGH (14q32) rearrangement
t(1;19)(q23;p13.3) - PBX1/TCF3
t(11;19)(q23;p13.1) - MLL/ELL
t(11;19)(q23;p13.3) - MLL/MLLT1 or MLL/ENL
t(12;21)(p13;q22) - TEL/AML1 or ETV6/RUNX1
t(4;11)(q21;q23) - AFF1/MLL or AF4/MLL
t(9;11)(p22;q23) - MLLT3/MLL or AF9/MLL
t(9;22)9q34;q11.2) - BCR/ABL1
t(X;14)(p22.3;q32) - CRLF2/IGH
t(Y;14)(p11.32;q32) - CRLF2/IGH
t(6;11)(q27;q23) - MLLT4/MLL or AF6/MLL
t(10;11)(p12;q23) - MLLT10/MLL or AF10/MLL
MLL or KMT2A (11q23) rearrangement
MYC (8q24.1) rearrangement
ABL2 (1q25) rearrangement
PDGFRB (5q33) rearrangement
JAK2 (9p24.1) rearrangement
ABL1 (9q34) rearrangement
CRLF2 (Xp22.33) or (Yp11.32) rearrangement
P2RY8 (Xp22.33) or (Yp11.32) rearrangement
Ph-like ALL
BCR-ABL1 like ALL
iAMP21
Hypodiploidy/pseudo-hyperdiploid
Hyporiploid/Near-Triploid
Philadelphia-like ALL

This B-cell acute lymphoblastic leukemia (B-ALL) fluorescence in situ hybridization (FISH) test may be ordered in 4 distinct ways allowing different combinations of probes to be utilized based on the clinical question. The 4 ways this B-ALL FISH test can be ordered are as follows:

-Standard (diagnostic) B-ALL FISH panel

-Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL) panel

-Combined-Standard (diagnostic) B-ALL FISH panel + Ph-like ALL panel

-Individual B-ALL FISH probes (per client request)

The specific B-ALL FISH panel or FISH probes requested must be noted on the request form or in the reason for referral. If no specific panel or FISH probe request is indicated, the "Standard (diagnostic) B-ALL FISH panel" will be performed.

The Standard (diagnostic) B-ALL FISH panel includes testing for the following abnormalities, using the FISH probes listed:

Hyperdiploidy, +4,+10,+17: D4Z1/D10Z1/D17Z1

t(12;21)(p13;q22), ETV6/RUNX1 fusion, ETV6/RUNX1 D-FISH

iAMP21, RUNX1 amplification, ETV6/RUNX1 D-FISH

t(9;22)(q34;q11.2), BCR/ABL1 fusion, BCR/ABL1 D-FISH

t(1;19)(q23;p13), PBX1/TCF3 fusion, PBX1/TCF3 D-FISH

t(11q23;var), MLL (KMT2A) rearrangement, MLL (KMT2A) break-apart

del(9p), CDKN2A deletions, CDKN2A/D9Z1

t(14q32;var), IGH rearrangement, IGH break-apart

del(17p), TP53 deletions, TP53/D17Z1

8q24.1 rearrangement, MYC break-apart

t(Xp22.33;var) or t(Yp11.32;var), P2RY8 rearrangement, P2RY8 break-apart

t(Xp22.33;var) or t(Yp11.32;var), CRLF2 rearrangement, CRLF2 break-apart

-When an MLL (KMT2A) rearrangement is identified, reflex testing will be performed to identify the translocation partner. Probes include identification of t(4;11)(q21;q23) AFF1/MLL, t(6;11)(q27;q23) MLLT4/MLL, t(9;11)(p22;q23) MLLT3/MLL, t(10;11)(p13;q23) MLLT10/MLL, t(11;19)(q23;p13.1) MLL/ELL, or t(11;19)(q23;p13.3) MLL/MLLT1.

-When an IGH and/or CRLF2 rearrangement is identified, reflex testing will be performed using the CRLF2/IGH fusion probe set to identify a potential t(X;14)(p22.33;q32) or t(Y;14) (p11.32;q32) "cryptic translocation."

-When an extra signal of ABL1 is identified in BCR/ABL1 testing, reflex testing will be performed using the ABL1 break-apart probe set to identify the presence or absence of an ABL1 rearrangement.

-If a MYC rearrangement is identified, break-apart probe sets for BCL2 and BCL6 will be performed.

*The "Standard (diagnostic) B-ALL FISH panel" will be automatically reflexed to the Philadelphia Ph-like ALL panel on pediatric and young adult patients (age <30) who demonstrate normal or nonclassical abnormalities on the Standard (diagnostic) panel. In other circumstances, the Ph-like ALL panel may be recommended and the client notified before performing this testing.

The Ph-like ALL panel includes testing for the following abnormalities using the FISH probes listed:

-t(1q25;var), ABL2 rearrangement, ABL2 break-apart

-t(5q33;var), PDGFRB rearrangement, PDGFRB break-apart

-t(9p24.1;var), JAK2 rearrangement, JAK2 break-apart

-t(9q34;var), ABL1 rearrangement, ABL1 break-apart

-t(Xp22.33;var) or t(Yp11.32;var), P2RY8 rearrangement, P2RY8 break-apart

-t(Xp22.33;var) or t(Yp11.32;var), CRLF2 rearrangement, CRLF2 break-apart

-monosomy 7 or del(7p), IKZF1 deletions, IKZF1/CEN7 enumeration

-When a PDGFRB rearrangement is identified, reflex testing may be performed using the PDGFRB/ETV6 fusion probe set to identify a potential t(5;12)(q33;p13) translocation.

-When a CRLF2 rearrangement is identified, reflex testing will be performed using the CRLF2/IGH fusion probe set to identify a potential t(X;14)(p22.33;q32) or t(Y;14) (p11.32;q32) "cryptic translocation."

-If an ABL1 rearrangement is identified, reflex testing will be performed using the BCR/ABL1 dual-color, double fusion FISH probe set to evaluate for the presence or absence of BCR/ABL1 fusion.

We recommend the following testing algorithm for patients with B-acute lymphoblastic leukemia (B-ALL):

-At diagnosis, standard (diagnostic) B-ALL FISH panel and/or conventional chromosome studies (CHRBM / Chromosome Analysis, Hematologic Disorders, Bone Marrow) should be performed. If there is limited specimen available for CHRBM, this test will be performed instead.

-If the patient clinically relapses, a conventional chromosome study is useful to identify cytogenetic changes in the neoplastic clone or the possible emergence of a new therapy-related myeloid clone.

This test includes a charge for application of the first probe set (2 FISH probes) and professional interpretation of results. Additional charges will be incurred for all reflex probes performed. Analysis charges will be incurred based on the number of cells analyzed per probe set. If no cells are available for analysis, no analysis charges will be incurred.

If this test is ordered and the laboratory is informed that the patient is on a COG protocol, this test will be canceled and automatically reordered by the laboratory as COGBF / B-Lymphoblastic Leukemia/Lymphoma, Children's Oncology Group Enrollment Testing, FISH, Varies.

25460BFCCBody Fluid Cell Count
​Cell Count Body Fluid, BF Cell Ct
​Total Nucleated Cell Count (WBC), Red Blood Cell Count
22415BFCC/DBody Fluid Cell Count and Manual Differential (Not CSF)
Cell Count and Differential, Body Fluid, BFD Cell Ct + Diff​
Total Nucleated Cell Count (WBC), Red Blood Cell Count, Percent neutrophils, lymphocytes, monocytes, eosinophils, and basophils and any abnormal nucleated cells present including blasts and nucleated red blood cells.​
25463BAPBone Alkaline Phosphatase
Bone-specific Alkaline phosphatase, Ostase
22381B.M.Bone Marrow Differential
​Bone Marrow Biopsy, Bone Marrow Aspirate, Bone Marrow Exam
23165BORDPCRBordetella by PCR
​Pertussis PCR, Whooping Cough by PCR, Parapertussis PCR
25561BRAFTSOBRAF Mutation Analysis (V600E), Tumor (BRAFT)
V600E, BRAF
BRAF Mutation Analysis, Slide Review
25560BRAFDSOBRAF V600E/V600K Somatic Mutation Analysis, Tumor (BRAFD)

Anaplastic thyroid carcinoma
BRAF
BRAF mutation
BRAFD
Brain cancer
Circulating tumor cells
Circulating tumor DNA
CNS tumor
Colon cancer
Colorectal cancer
Craniopharyngioma
Erdheim-Chester disease
Glioma
Hairy Cell leukemia
Histiocytic lesion
Liquid biopsy
Lung cancer
Melanoma
Papillary thyroid carcinoma
V600E
V600K

Slide review, BRAF Mutation Analysis
23094CA2729Breast Cancer Antigen (CA 27.29)
Biomira Truquant BR, Breast Cancer Tumor Markers, Breast Carcinoma, Cancer Antigen 27.29 , (CA 27.29), MAM 6, Milk Mucin, CA 27-29
22383BCABreast Cancer Antigen 15-3
Breast Ca Ag 15-3 (BCA)​
22384BRUCSOBrucella Abortus Serology (SS02002)
 Brucellosis, Undulant fever, B. abortus, Brucellosis Agglutinins

Quantitative direct agglutination procedure for the detection of antibody to B. abortus, B. melitensis, and B. suis.

Antibodies to Brucella canis, a rare cause of brucellosis, are not detected by this method.​

23109BNPB-Type Natriuretic Peptide
​BNP, Brain-type Natriuretic peptide
26078BPSOBullous Pemphigoid, BP180 & BP230, IgG Antibodies, Serum (BPAB)

BP 180

BP 230

Bullous Pemphigoid

25152BUPBuprenorphine, Urine
Buprenex, Suboxone, Subutex, Temgesic​
25374CO-BUPBuprenorphine, Urine, Confirm Only by LCMS
Buprenex, Suboxone, Subutex, Temgesic​
24755BUPSCBuprenorphine, Urine, Qual
​Buprenex, Suboxone, Subutex, Temgesic
23249BUPRSOBupropion, Serum (178)
Wellbutrin®; Zyban®